RESEARCH MONOGRAPH · KDC-MN-395
Beta-Alanine
Beta-alanine is a non-protein amino acid that serves as the rate-limiting ingredient for muscle carnosine synthesis. Supplementing for four to twelve weeks raises muscle carnosine by 30 to 80 percent, which improves the muscle's ability to buffer the acid build-up that limits high-intensity exercise. The ergogenic benefit is most reliable for efforts lasting one to four minutes (where lactate buffering is the bottleneck), with meta-analyses showing about 2 to 3 percent improvement. The signature side effect is paresthesia, the harmless but distinct tingling sensation in the face and limbs, attributed to peripheral nerve activation by free beta-alanine. Sustained-release formulations and split dosing reduce the tingle. The relevant pharmacokinetic compartment is muscle carnosine, not plasma. Reference lactate-buffering ergogenic in sport science. Not stocked by Kodiac. This monograph is provided for research and educational reference.
Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.
Beta-amino acid / carnosine precursor
A non-proteinogenic beta-amino acid; the rate-limiting precursor for muscle carnosine synthesis; an ergogenic supplement that buffers exercise-induced acidosis.
Abstract
Beta-alanine (3-aminopropanoic acid; CAS 107-95-9; molecular formula C3H7NO2; molecular weight 89.09) is a non-proteinogenic beta-amino acid produced endogenously by uracil and dihydrouracil degradation. The compound is the rate-limiting precursor for skeletal muscle carnosine (beta-alanyl-L-histidine) synthesis. Pharmacologically, supplementation over 4 to 12 weeks elevates muscle carnosine by approximately 30 to 80 percent, increasing the muscle's intracellular pH-buffering capacity during high-intensity exercise. The ergogenic effect is most pronounced for exercise durations of 1 to 4 minutes (where lactate buffering is rate-limiting); meta-analyses show approximately 2 to 3 percent improvement in such efforts. The characteristic side effect is paresthesia (tingling, particularly on face and extremities) attributed to peripheral nerve activation by free beta-alanine; sustained-release formulations and split dosing reduce this. Plasma half-life is approximately 25 minutes; the relevant pharmacokinetic compartment is muscle carnosine, which has a much longer turnover. Used as the canonical lactate-buffering ergogenic in sport science.
Mechanism of action
Rate-limiting carnosine synthesis precursor; supplementation expands muscle carnosine pool and intracellular pH-buffering capacity during exercise.
Reported research dose ranges
Reported research dose ranges vary across the published literature.
References
- Trexler ET, et al. International Society of Sports Nutrition position stand: beta-alanine. J Int Soc Sports Nutr 2015.
- Hoffman J, et al. Beta-alanine and the hormonal response to exercise. Int J Sports Med 2008.
- Saunders B, et al. Beta-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med 2017.
Read the full monograph
Available as a research-use-only PDF download.
The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.
FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.